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Abstract
Background: Vitamin A deficiency (VAD) is of major public health significance; it is a risk factor for childhood
deaths from diarrhoea and measles in low and middle-income countries and an important cause of preventable
childhood blindness in low income countries. Vitamin A supplementation (VAS) is being implemented in many LMICs
and high coverage reduces the prevalence of blinding corneal diseases in children. However, national estimates of
coverage may not reveal any inequities in intra country coverage. The aim of this study is to assess factors influencing
VAS coverage and also assess the relationship between VAS coverage and childhood corneal blindness in Nigeria.
Methods: Data were collected from the Nigeria Demographic and Health Survey (NDHS) 2013 and the published
literature on population-based childhood blindness surveys in Nigeria. The main outcome measure was the proportion
of eligible children who received VAS in the last 6 months preceding the survey. Study factors comprised a range of
socioeconomic, and individual factors. Data were analysed using STATA V.12.1 (Statcorp, Texas). To explore the effects
of the independent variables on VAS coverage, bivariate and multivariate regression was done. Variables with p < 0.05
in the final multivariable model were considered as independent factors. For the population-based childhood blindness
surveys, aggregated and disaggregated data were used. Causes of blindness were stratified into corneal blindness and
‘others’. Odds ratios were computed to determine the odds of developing corneal blindness in each geopolitical region.
Tests of significance were set at the 95% level.
Results: The total VAS coverage in 2013 was 41.5%. VAS coverage was inequitable. Children with very educated mothers
(OR 3.27 p < 0.001), from the south-south region (OR 2.38 p < 0.001) or in the highest wealth quintile (OR 2.81 p < 0.001)
had higher odds of receiving VAS. The northwest zone had the lowest VAS coverage and the highest prevalence
of corneal blindness.
Conclusion: Regional and socioeconomic inequities in VAS exist in Nigeria and these may have grave implications for
the causes of childhood blindness. The development and implementation of context specific and effective strategies
are needed to reduce these inequities in VAS.
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Background
Vitamin A deficiency (VAD) is a major public health
problem in low- and middle-income countries [1, 2];
It is a risk factor for under-five mortality from mea-
sles and diarrhoea [2] and is one of the most import-
ant causes of preventable childhood blindness in low
income countries [3].
The primary cause of VAD is lack of an adequate in-
take of vitamin A. Children also have relatively high re-
quirements for vitamin A, and demand for vitamin A
increases during infections [3]. Globally, VAD affects an
estimated 190 million preschool children [4] of which
56.4 million are in Africa [3]. A recent review indicated
that although only 1.7% of the under-five mortality in
low- and middle-income countries was attributed to
VAD, 95% of these deaths occurred in sub-Saharan
Africa and south Asia where 2% of deaths (same in both
regions) were attributed to VAD [2]. In Nigeria, VAD is
of severe public health importance, affecting over 20% of
preschool age children. Strategies to prevent VAD in-
clude nutritional education to encourage dietary diversi-
fication and local production of vitamin A rich foods,
food fortification with vitamin A, promotion of breast-
feeding, the use of oral rehydration therapy to treat diar-
rhoea, higher measles vaccination coverage and vitamin
A supplementation (VAS) [3]. It has been shown that
VAS in pre-school children reduces morbidity and
all-cause mortality in pre-school children [1].
VAS is recommended in all countries where the
under-five mortality rate (U5MR) exceeds 70 deaths per
1000 live births [5]. In Nigeria the U5MR is currently
108/1000 live births [6], which is over four times the
sustainable development goal target of 25 per 1000 live
births [7]. VAS has been found to be one of the most
cost effective strategies for improving child survival,
hence it is being implemented as a child survival strategy
in countries where VAD is of public health significance
[4, 5]. To prevent VAD in many LMICs including
Nigeria, vitamin A is delivered routinely to children aged
6–59 months as stipulated in the Integrated Manage-
ment of Childhood Illness (IMCI) strategy at frontline
health facilities, during bi annual Maternal Neonatal and
Child Health Weeks (MNCHW) and National Immun-
isation Plus Days by trained healthcare workers [5, 8].
To maximize the potential of this intervention, it is cru-
cial for countries to guarantee a high coverage of VAS.
Coverage is an important implementation indicator,
measuring the proportion of individuals who need the
intervention that actually receive it [9]. VAS is being im-
plemented in many LMICs and although coverage rates
of up to 85% have been reported [10], VAS coverage is
below this target in many countries including Nigeria
[11]. However, national estimates of coverage may not
reveal any inequities in intra country coverage. Analysis
of subnational data will help to identify and assess
within-country inequities in VAS coverage [9].
VAS reduces blinding corneal diseases in children. A
systematic literature review and metanalysis of existing
data shows that VAS in preschool children reduces cor-
neal blinding lesions by almost 70% [12]. It is expected
that countries or regions with high VAS coverage should
have a lower prevalence of blinding corneal diseases.
VAS coverage is recorded in regularly conducted na-
tional demographic and health surveys in Nigeria. In
addition, population-based childhood blindness surveys
have been conducted in three geo-political zones in
Nigeria (Southeast [13], South-south [14] and Northwest
[15] zones) and population-based estimates and causes
of childhood blindness in these zones have been re-
ported. The aim of this study is to assess factors influen-
cing VAS coverage and also assess the relationship
between VAS coverage and childhood corneal blindness
in Nigeria.
The findings from this research will provide evidence-
based information to policy makers and programme im-
plementers on factors influencing VAS coverage and the
relationship between VAS coverage and childhood cor-
neal blindness.
Methods
Data sources
The data used were collected from the Nigeria Demo-
graphic and Health Survey (NDHS) 2013 and the pub-
lished literature on population-based childhood blindness
surveys in Nigeria. The Demographic and Health Surveys
in Nigeria are implemented by the National Population
Commission, with developmental assistance from partners
such as the United Nations Population Fund (UNFPA)
and the United Kingdom Department for International
Development (DFID).
A steering committee is responsible for coordination
and oversight and consists of high-level stakeholders
from the National Bureau of Statistics, the Ministry of
Health and the National Population Commission. The
goal of the NDHS is to generate data to assist policy
makers make informed policy choices and develop strat-
egies for improving population health outcomes [16].
The NDHS is a nationally representative source of data
on demographic and health statistics and collects infor-
mation on child health characteristics, including mater-
nal health factors, from a nationally representative
sample of households. Sample selection was done by
two -stage cluster sampling- first by selecting clusters
from a list of enumeration areas, next by systematically
selecting households from a list in the selected clusters
using the 2006 census frame.
Data collection was by questionnaire. For the females,
only women aged 15–49 were selected. Information sought
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included socio-demographic characteristics - age, religion,
education, literacy, marriage, health characteristics, fertility
preferences, antenatal, delivery, and postnatal care; breast-
feeding and infant feeding practices, vitamin A supplemen-
tation, child immunisation and childhood illnesses. For
mothers with children 6–59months of age, data collected
on relevant immunisations and vitamin A supplementa-
tion were based on mother’s recall and immunisation
card where available. In addition, the household wealth
index was calculated as a score of weighted household
assets (such as ownership of vehicles or household fa-
cilities) and national level wealth quintiles were ob-
tained. The response rate of women 15–49 years in the
2013 NDHS was 97.6% [16]. The detailed methodology
can be found elsewhere [16].
Data sources for the childhood blindness surveys were
from three population based childhood blindness sur-
veys in three geopolitical zones in Nigeria; Northwest
[15], South east [13] South-south [14] zones. These three
studies used the key informant methodology to identify
children suspected of having visual impairment, to de-
termine population-based estimates and the causes of
childhood blindness [17].
Data extraction
The Children’s Data Recode File component of the data
from the Nigeria Demographic and Health Survey
(NDHS) for 2013 was retrieved as the database for this
study. After reviewing the detailed data coding, further
data cleaning was performed by the researchers. Data for
24,327 children aged 6–59months were included in this
analysis.
VAS coverage indicator
For the NDHS survey, VAS coverage was defined as the
percentage of children 6–59months who received VAS
within the 6 months preceding the survey [16].
Study factors
Study factors comprised a range of socioeconomic, and
individual factors, and their inclusion in the present
analysis was based on findings from similar previously
published studies in Sub-Saharan African countries like
Guinea [18] Ethiopia [19] and a UNICEF summary of
global VAS coverage [4] where an association was
found between these variables and VAS coverage. These
include age of the index child, urban/rural residence,
geopolitical zone, mothers’ educational attainment
(categorised as no schooling, primary or secondary and
higher education), and household wealth index. The
household wealth index was used to categorise house-
holds into wealth quintiles (as ‘poorest’, ‘poorer’, ‘middle’,
‘richer’ or ‘richest’) [16].
Statistical analysis
Data were analysed using STATA V.12.1 (Statcorp,
Texas). To allow for the cluster sampling survey design
used in the NDHS, appropriate weights were used to re-
store the representativeness of the sample and analyses
were performed using “svy” commands in STATA.
The main outcome measure was the proportion of
children (6–59 months) who received at least one dose
of Vitamin A in the 6 months preceding the survey. To
explore the effects of the independent variables on VAS
coverage, bivariate regression models were fitted separ-
ately for the 2013 NDHS data set. Subsequently, a mul-
tiple regression model was developed to assess the
effects of variables found to be significant at p ≤ 0.05.
These included socioeconomic, maternal education and
regional variables. Models were restricted to children
aged 6–59months, living with respondents (eligible
women aged 15–49 years). Both crude and adjusted odds
ratios (OR) are presented with 95% confidence intervals.
All tests were two-sided, and variables with p < 0.05 in
the final multivariable model were considered as inde-
pendent factors.
For the population-based childhood blindness surveys,
causes of blindness were classified as corneal blindness
and other causes. Odds ratios were computed to deter-
mine the odds of corneal blindness in each geopolitical
region. Tests of significance were set at the 5% level.
Results
The total VAS coverage for children 6–59months in
Nigeria in 2013 was 41.5%. There was no gender dispar-
ity in the coverage: females 41.8%; males 41.3% (Odds
Ratio (OR) 1.02, 95% confidence interval (CI) 0.96–1.09,
p = 0.47).
VAS coverage was significantly higher in urban
(53.5%) than in rural areas (34.7%) (p < 0.001), as shown
in Fig. 1, and the crude OR for urban versus rural was
2.16 p < 0.001 while the adjusted OR was 0.87 p = 0.001.
The lowest VAS coverage was in the 6–8 month age
group (31.2%) as shown in Fig. 2. Using the 6–11month
age group as the reference population, the adjusted odds
ratio for VAS coverage for all the other age groups was
significantly higher (Table 1). The VAS coverage for chil-
dren aged 12–59months was 42.3%.
The North West zone had the lowest VAS coverage
(26.1%) and South South had the highest (65.5%) as
shown in Table 1. The level of mother’s education and
wealth quintile were significantly correlated with VAS
coverage in univariate and multivariable analyses.
The North West zone had the highest proportion of
corneal blindness (affecting 55% of 20 children), which
was significantly higher than in the South East zone
(13% of 15 children) and South South zone (16% of 108
children) as shown in Table 2.
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Discussion
Our study shows that the VAS coverage for Nigeria
(41.5%) is only half that recommended by the World
Health Organisation (i.e., ≥80%) for children aged 6–59
months. This threshold is thought to be the minimum
VAS coverage required for countries to achieve a meas-
urable reduction in childhood mortality [5]. Our esti-
mate is likely to be a minimal estimate as there is
anecdotal evidence that during the MNCHWs, one
mother may take several children to be immunized and
receive vitamin A, including those from neighbouring
households, without immunisation cards, so no formal
records are made.
Our study showed no gender disparity in VAS cover-
age, similar to studies in Ethiopia and India [20, 21]. In
some communities in northwest Nigeria and in Sierra
Leone, it has been reported that VAS is not only facility
based but also community based and health workers
who adopt a door to door approach do not discriminate
by gender [22, 23]. This may not be applicable to all
communities as it has also been reported that VAS in
Nigeria is mainly facility based [8]. However, a study in
Ghana reported a higher female VAS coverage [24].
In our study, in the unadjusted model, the odds of
urban children receiving VAS was twice that of their
rural counterparts and an almost 20% difference in
coverage. However, in the adjusted model, this was re-
versed with urban children marginally less likely to re-
ceive VAS. The higher crude odds could be explained by
the higher number of uneducated and poorer mothers in
rural areas. This is similar to research in India [20] and
Ethiopia [19] where the crude odds ratio for VAS
Fig. 1 VAS coverage in urban and rural areas
Fig. 2 VAS coverage by age group
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Table 1 Showing VAS coverage by child, maternal and sociodemographic characteristics
Variable n % OR 95% (LCI-UCI) p Adjusted OR 95% (LCI-UCI) p
Child Factors
Age group
6_11 3195 35.8 1 1
12_23 5717 44.1 1.43 (1.29–1.59) < 0.001 1.55 (1.39–1.73) < 0.001
24_35 5111 43.1 1.35 (1.21–1.50) < 0.001 1.46 (1.30–1.64) < 0.001
36_47 5322 40.5 1.22 (1.09–1.35) < 0.001 1.37 (1.23–1.54) < 0.001
48_59 4982 41.3 1.26 (1.13–1.40) < 0.001 1.42 (1.27–1.60) < 0.001
Sex
Female 12,042 41.3 1
Male 12,285 41.8 1.02 (0.96–1.09) 0.47
Maternal Factors
Mother’s Education
No education 11,198 25 1 1
Primary 5005 47.9 2.75 (2.54–2.98) < 0.001 1.66 (1.50–1.82) < 0.001
Secondary 6560 59.6 4.41 (4.09–4.76) < 0.001 2.02 (1.82–2.24) < 0.001
> Secondary 1564 75 8.97 (7.76–10.37) < 0.001 3.27 (2.75–3.89) < 0.001
Sociodemographic Factors
Residence
Rural 16,030 34.7 1 1
Urban 8297 53.5 2.16 (2.03–2.30) < 0.001 0.87 (0.80–0.94) 0.001
Region
North West 7566 26.1 1 1
North East 4936 31.3 1.28 (1.18–1.41) < 0.001 1.25 (1.14–1.37) < 0.001
North Central 3644 45.5 2.36 (2.15–2.60) < 0.001 1.56 (1.41–1.73) < 0.001
South South 2930 65.5 5.37 (4.82–5.98) < 0.001 2.38 (2.10–2.69) < 0.001
South East 2190 56.7 3.71 (3.30–4.16) < 0.001 1.76 (1.53–2.00) < 0.001
South West 3061 65.3 5.32 (4.80–5.91) < 0.001 2.3 (2.04–2.60) < 0.001
Wealth Quintile
Poorest 5324 21 1 1
Poorer 5504 31 1.69 (1.53–1.86) < 0.001 1.35 (1.22–1.50) < 0.001
Middle 4859 43.3 2.86 (2.59–3.16) < 0.001 1.72 (1.54–1.92) < 0.001
Richer 4589 53.2 4.26 (3.85–4.71) < 0.001 2.06 (1.82–2.34) <0.001
Richest 4051 67.6 7.83 (7.03–8,71) <0.001 2.81 (2.41–3.28) <0.001
Table 2 Showing proportion of childhood corneal blindness by geographical region
Geopolitical
zone
Corneal blindness Other childhood blindness Odds ratio 95% UCI-LCI p-value
n % n %
North West 11 55 9 45 1
South East 2 13 13 87 0.13 0.02–0.71 0.02
South South 17 16 91 84 0.15 0.05–0.42 0.003
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coverage showed higher coverage in urban areas, but
this was reversed after adjusting for confounders. Our
data show that the youngest age group ((6–11months)
had the lowest VAS coverage, similar to studies in
Ethiopia [24] and Nepal [25]. It has been suggested that
low coverage among children in this age group may be
because some of the children aged 6–11months would
not have been eligible for VAS within the 6 months pre-
ceding the survey [25]. Our results support this hypoth-
esis as the 6–8 month age group had the lowest VAS
coverage. In a VAS coverage survey in Guinea, con-
ducted 1 month after a VAS event, VAS coverage among
6–11 months old children was similar to children 12–59
months of age [18].
The National Strategic Plan of Action for Nutrition
(NSPAN) provides an overview of the priority nutrition
interventions and strategic directions for nutrition in the
health sector in Nigeria, up to 2019 [26]. There is a bold
and ambitious plan to increase VAS coverage in
pre-schoolers to 95% by the end of 2018. However, the
2011 Multiple Indicator Report Survey showed a VAS
coverage of 65% [27] while our results show a coverage
of 41.5%. To achieve target coverage, there is an urgent
need to address both the demand and supply side of
VAS. Identifying inequities in coverage is an initial step
to developing appropriate strategies to address them.
We found evidence of socioeconomic and regional in-
equities in our study.
Regional differences
The odds of a child in the South-south zone receiving
VAS were almost two and a half times that of a child in
the northwest zone. This zonal inequity has also been
recorded in two previous NDHS in Nigeria [28, 29].
Wide intra country disparities in VAS have been re-
ported in several countries [18–20]. In northern Nigeria
which is predominantly muslim, cultural and religious
beliefs may affect the uptake of health interventions, es-
pecially for maternal and child health [22, 30, 31]. It has
been reported that issues pertaining to fathers’ approval
significantly affect the uptake of immunisation or VAS
in the northwest [22] and northeast [32] regions in
Nigeria. However, the contribution of fathers’ approval
to poor uptake of health intervention in the northern
geopolitical zones needs to be interpreted with caution
as the same may apply in other areas of the country
where similar studies were not done. It was previously
suggested that supply- side disparities in distribution of
health facilities was a contributory factor for the health
inequities between northern and southern Nigeria. How-
ever, recent research suggests that this is not the case and
residents in the north have more physical access to vaccin-
ation centres than their southern counterparts suggesting
that any disparities are likely due to socio-cultural
differences [33]. This suggests that strategies to improve
the uptake of health interventions should include targeted
advocacy to community and religious leaders and male
heads of households. A qualitative study on factors affect-
ing the uptake of immunisation in Nigeria highlights the
importance of sensitizing religious leaders especially in
northern Nigeria [34].
Mothers’ education and socioeconomic status
There is a growing body of literature that suggests that
mothers’ education and socioeconomic status correlate
directly with improved health outcomes and our study
was no exception. In our study, the odds of the child of
a mother with higher education receiving VAS was over
three times that of the child of a mother without educa-
tion. This is similar to results from Ghana [24] and India
[20]. This may be because maternal education confers
more awareness of the benefits of VAS. Research from
Mali shows no disadvantage in VAS coverage for the
children of uneducated mothers. The decentralised and
context specific approach to disseminating health related
information implemented in Mali may have reduced the
inequity in access to health information [35]. Also, in a
study in Sierra Leone, while data on socioeconomic and
regional inequities are unavailable, high VAS coverage was
achieved within clusters ranging from 86.7 to 97.8%. This
was made possible by extensive and context specific social
mobilisation [23]. This suggests that health promotion
messages that are readily understandable by women with-
out formal education need to be developed and scaled up.
The Africa Vaccination Week (AVW) is an initiative
devised by the WHO AFRO to promote vaccination and
ensure equity and access to its benefits. Several countries
have used the Africa Vaccination Week to boost cover-
age of maternal and childhood health interventions, in-
cluding VAS [36]. Nigeria’s equivalent of the (AVW) is
the bi-annual Maternal New-born and Child Health
Week (MNCHW) which started in 2010 and targets
children under 5 years of age, pregnant women and
women of child-bearing age with specific interventions.
However, a recent evaluation of the initiative reveals that
the current model of the MNCHW has failed to reach
the most marginalized and there is no evidence that the
MNCHW has significantly contributed to coverage of
essential MNCHW interventions in Nigeria [8]. It has
been suggested that failure of MNCHWs to reach the
most marginalised populations in Nigeria is the because
the bulk of interventions is facility-based and not
community-based, and may not address the barriers of
distance, opportunity costs and security [8].
This is reflected in our study which shows a low VAS
coverage and high coverage disparities.
However, the NSPAN recommends that VAS be deliv-
ered not only in health facilities but also in community
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structures and campaigns/outreaches [26]. This has the
potential to increase VAS coverage.
In addition, we can learn from the successful strat-
egies of other African countries that have achieved
high and equitable VAS coverage [18, 35] Such strat-
egies include: developing context specific VAS strat-
egies that are culturally and socially acceptable to the
specific target audience [35], and maximizing the po-
tential of the African Vaccination week by meticulous
planning, coordination, supervision training and social
mobilisation to ensure universal coverage for maternal
and child health interventions [23].
Unless stakeholders in Nigeria develop and implement
feasible strategies that target underserved and margina-
lised populations, achieving VAS coverage targets will be
high on rhetoric and low on delivery.
Implications of VAS coverage for childhood blindness
In many LMICs, corneal blindness from VAD and mea-
sles, which used to be the commonest cause of
childhood blindness, is decreasing due to measles im-
munisation and VAS [37, 38]. In the southeast and
south-south zones, corneal blindness was responsible for
less than a sixth of all childhood blindness but in the
northwest zone with the lowest VAS coverage, over half of
children were blind from corneal scarring. Corneal blind-
ness from VAD or measles is a reflection of individual
(care giver), community and systemic lapses; there is need
for care givers and community members to be sensitised
about the importance of child health interventions and
the consequences of non-compliance; it is crucial for
health workers to understand the importance of VAS and
measles immunisation [39]; finally, it is imperative that
health systems deliver effective strategies to resolve both
demand and supply side constraints to providing universal
coverage with child health interventions.
Limitations
In interpreting the results of this study and other NDHS
studies, a few methodological limitations and strengths
should be taken into consideration. The major strengths
of the study are its national representativeness, large
sample size and the availability of individual and house-
hold level factors which could influence VAS coverage.
A major limitation is that the data on VAS available for
analysis did not indicate whether data came from obser-
vation of children’s immunization cards, or from recall
by mothers. The latter may be subject to recall bias de-
pending on the interval between VAS and the NDHS
survey.
Finally, analyses of the childhood blindness data should
be interpreted with caution as these are population-based
estimates derived from studies with small sample sizes
and the data may not be normally distributed. In addition,
the key informant method has limitations, and may not
identify all children who are blind in a given population.
However, due the challenges in the epidemiological inves-
tigation of relatively rare diseases like childhood blindness,
this method has been used to provide population-based
estimates of rare diseases and disability [17].
Conclusion
Many studies have shown that VAD increases the risk of
childhood mortality and this can be prevented by VAS.
Regional and socioeconomic inequities in VAS exist in
Nigeria and these may have grave implications for the
causes of childhood blindness. The development and im-
plementation of context specific and effective strategies
are needed to reduce these inequities in VAS.
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